Media headlines about Rewalk Robotics (NASDAQ:RWLK) have trended somewhat positive on Friday, Accern reports. Accern ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Rewalk Robotics earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave press coverage about the medical device company an impact score of 46.2798840917946 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

These are some of the news stories that may have effected Accern Sentiment Analysis’s scoring:

A number of equities research analysts have recently weighed in on RWLK shares. Oppenheimer set a $3.00 price objective on shares of Rewalk Robotics and gave the stock a “buy” rating in a report on Monday, January 1st. Zacks Investment Research upgraded shares of Rewalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 price target for the company in a report on Thursday, November 9th. Canaccord Genuity reiterated a “buy” rating and set a $3.00 price target on shares of Rewalk Robotics in a report on Monday, November 6th. Jefferies Group lowered their price target on shares of Rewalk Robotics from $8.00 to $5.00 and set a “buy” rating for the company in a report on Friday, November 3rd. Finally, Piper Jaffray Companies reiterated a “buy” rating and set a $3.00 price target on shares of Rewalk Robotics in a report on Sunday, January 7th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $2.83.

Rewalk Robotics (NASDAQ:RWLK) traded down $0.03 during trading hours on Friday, reaching $1.05. 193,039 shares of the company were exchanged, compared to its average volume of 284,200. Rewalk Robotics has a 52 week low of $1.05 and a 52 week high of $3.20. The company has a quick ratio of 1.65, a current ratio of 2.02 and a debt-to-equity ratio of 7.46. The company has a market cap of $31.09, a price-to-earnings ratio of -0.66 and a beta of 0.79.

Rewalk Robotics (NASDAQ:RWLK) last posted its quarterly earnings results on Thursday, November 2nd. The medical device company reported ($0.22) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.32) by $0.10. Rewalk Robotics had a negative net margin of 346.14% and a negative return on equity of 568.25%. The company had revenue of $1.70 million during the quarter, compared to analyst estimates of $1.63 million. During the same period in the prior year, the business posted ($0.62) EPS. The firm’s revenue was up 21.4% compared to the same quarter last year. research analysts predict that Rewalk Robotics will post -1.14 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at

About Rewalk Robotics

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.

Insider Buying and Selling by Quarter for Rewalk Robotics (NASDAQ:RWLK)

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with's FREE daily email newsletter.